Xtant Medical Holdings, Inc. provided unaudited pro forma condensed consolidated financial information in relation to recent divestitures and debt reduction.
The pro forma statements include adjustments for the sale of certain assets, equity securities, and debt reduction related to Companion Spine, LLC.
These adjustments are presented as if they had occurred on specific dates to reflect the impact on the company's financial position.
Divestitures Impact
Sale of assets and equity securities to Companion Spine, LLC with corresponding debt reduction.
Financial Statement Dates
Pro forma statements for September 30, 2025, and the nine months ended September 30, 2025, reflect adjusted balances.
Intended Use
The pro forma financial information is for informational purposes and does not project future financial performance.
- The divestitures and debt reduction have a significant impact on Xtant Medical Holdings, Inc.'s balance sheet and financial statements.
- These strategic moves are expected to reshape the company's asset structure and improve liquidity in the near term.
Overall, Xtant Medical Holdings, Inc.'s proactive actions through divestitures and debt reduction show a strategic focus on optimizing its financial position and strengthening long-term viability in the industry.